Matches in Nanopublications for { ?s ?p "[Tumor cell with disruption of these cell cycle regulators can get a growth advantage and metastatic potential during tumor progression, especially p16/CDKN2 alterations may be associated with lymph node metastasis in ESCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP197377.RAAQ35W74-9VmqQ_gmsfJaOUGmEthQJZM4jeMj392R22g130_assertion description "[Tumor cell with disruption of these cell cycle regulators can get a growth advantage and metastatic potential during tumor progression, especially p16/CDKN2 alterations may be associated with lymph node metastasis in ESCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP197377.RAAQ35W74-9VmqQ_gmsfJaOUGmEthQJZM4jeMj392R22g130_provenance.
- NP317308.RAJf7wyyrCv4mJ4bPN0WsughHDXuBpqxHtda8Guveg1wM130_assertion description "[Tumor cell with disruption of these cell cycle regulators can get a growth advantage and metastatic potential during tumor progression, especially p16/CDKN2 alterations may be associated with lymph node metastasis in ESCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP317308.RAJf7wyyrCv4mJ4bPN0WsughHDXuBpqxHtda8Guveg1wM130_provenance.